987
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Paradoxical skin lesions induced by IL-17 inhibitors in SAPHO syndrome

, , , , , , & show all
Article: 2295239 | Received 10 Dec 2023, Accepted 11 Dec 2023, Published online: 28 Dec 2023

References

  • Cheng W, Li F, Tian J, et al. New insights in the treatment of SAPHO syndrome and medication recommendations. J Inflamm Res. 2022;15:1–3. doi: 10.2147/JIR.S353539.
  • Daoussis D, Konstantopoulou G, Kraniotis P, et al. Biologics in SAPHO syndrome: a systematic review. Semin Arthritis Rheum. 2019;48(4):618–625. doi: 10.1016/j.semarthrit.2018.04.003.
  • Lu J, Lu Y. Paradoxical psoriasis: the flip side of idiopathic psoriasis or an autocephalous reversible drug reaction? J Transl Autoimmun. 2023;7:100211. doi: 10.1016/j.jtauto.2023.100211.
  • Karamanakos A, Vergou T, Panopoulos S, et al. Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy. Eur J Dermatol. 2021;31(3):307–317. doi: 10.1684/ejd.2021.4056.
  • Munera-Campos M, Ballesca F, Carrascosa JM. Paradoxical reactions to biologic therapy in psoriasis: a review of the literature. Actas Dermosifiliogr (Engl Ed). 2018;109(9):791–800. doi: 10.1016/j.ad.2018.04.003.
  • Jiraskova Zakostelska Z, Reiss Z, Tlaskalova-Hogenova H, et al. Paradoxical reactions to anti-TNFα and anti-IL-17 treatment in psoriasis patients: are skin and/or gut microbiota involved? Dermatol Ther. 2023;13(4):911–933. doi: 10.1007/s13555-023-00904-4.
  • Kremenevski I, Sander O, Sticherling M, et al. Paradoxical reactions to biologicals in chronic inflammatory systemic diseases. Dtsch Arztebl Int. 2022;119(6):88–95.
  • Ucciferri C, Vecchiet J, Falasca K. Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases. 2020;8(19):4280–4285. doi: 10.12998/wjcc.v8.i19.4280.